19th Oct 2020 15:43
Amryt Pharma PLC - pharmaceutical company - Signs distribution agreement with Swixx Biopharma AG, under which Swixx will become exclusive distributor of lojuxta across 17 jurisdictions in Central and Eastern Europe.
The agreement will commence from October, and follows on from Amryt's appointment in June of Swixx as exclusive distributor of Myalepta across the CEE region.
Swixx will distribute lojuxta in Albania, Bosnia & Herzegovina, Bulgaria, Croatia, Estonia, Kosovo, Latvia, Lithuania, Montenegro, North Macedonia, Poland, Romania, Serbia and Slovakia. From January 2021, Swixx will expand distribution into Czech Republic, Hungary and Slovenia.
Current stock price: 199.75 pence
Year-to-date change: up 65%
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
AMYT.L